Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant Recipients

Kabar, Iyad; Hüsing‐Kabar, Anna; Maschmeier, Miriam; Völler, Carolin; Dümke, Marina; Schmidt, Hartmut; Heinzow, Hauke

doi:10.12659/aot.910278

Cited by 10 publications

(15 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…To our knowledge, PRISM has not previously been used in patients with UC, although the correlation of the burden of suffering measured by PRISM with conventionally used patient-and physician-reported outcomes is consistent with findings in other diseases [eg, RA, systemic lupus erythematosus, pain, advanced cancer, tinnitus, and liver disease]. [7][8][9][10][11][12]15 In these studies, PRISM SIS showed good correlations with other illness measures, with correlation strength varying according to diagnosis and also between samples with the same diagnosis. 15 One secondary objective of ICONIC was to compare patient and physician perceptions of disease.…”

Section: Discussionsupporting

confidence: 69%

“…PRISM has been validated as a reliable method for assessing suffering in several chronic conditions, but has not previously been used in patients with UC. [7][8][9][10][11][12] In addition, ICONIC investigated the multifaceted burden of disease in recently diagnosed patients with UC and compared the patient and physician perceptions of UC disease through the use of PRISM and the Simple Clinical Colitis Activity Index [SCCAI] tools.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Ghosh

Sensky

Casellas

et al. 2020

Journal of Crohn's and Colitis

View full text Add to dashboard Cite

Background The understanding the Impact of ulcerative COlitis aNd Its assoCiated disease burden on patients study [ICONIC] was a 2-year, global, prospective, observational study evaluating the cumulative burden of ulcerative colitis [UC] using the Pictorial Representation of Illness and Self-Measure [PRISM] tool that is validated to measure suffering, but not previously used in UC. Methods ICONIC enrolled unselected outpatient clinic attenders with recent-onset UC. Patient- and physician-reported outcomes including PRISM, the Short Inflammatory Bowel Disease Questionnaire [SIBDQ], the Patient Health Questionnaire [PHQ-9], and the Simple Clinical Colitis Activity Indexes [patient: P-SCCAI; physician: SCCAI] were collected at baseline and follow-up visits every 6 months. Correlations between these measures were assessed using Spearman’s rank correlation coefficient. Results Overall, 1804 evaluable patients had ≥1 follow-up visit. Over 24 months, mean [SD] disease severity measured by P-SCCAI/SCCAI reduced significantly from 4.2 [3.6]/3.0 [3.0] to 2.4 [2.7]/1.3 [2.1] [p<0.0001]. Patient-/physician-assessed suffering, quantified by PRISM, reduced significantly over 24 months [p<0.0001]. SCCAI/P-SCCAI, and patient-/physician-assessed PRISM, showed strong pairwise correlations [rho ≥0.60, p<0.0001], although physicians consistently underestimated these disease severity and suffering measures compared with patients. Patient-assessed PRISM moderately correlated with other outcome measures, including SIBDQ, PHQ-9, P-SCCAI, and SCCAI (rho = ≤-0.38 [negative correlations] or ≥0.50 [positive correlations], p<0.0001). Conclusion Over 2 years, disease burden and suffering, quantified by PRISM, improved in patients with relatively early UC. Physicians underestimated burden and suffering compared with patients. PRISM correlated with other measures of illness perception in patients with UC, supporting its use as an endpoint reflecting patient suffering.

show abstract

Section: Discussionsupporting

confidence: 69%

Section: Introductionmentioning

confidence: 99%

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Ghosh

Sensky

Casellas

et al. 2020

Journal of Crohn's and Colitis

View full text Add to dashboard Cite

show abstract

“…PRISM has been validated in a number of dermatological and non-dermatological disorders to measure illness-related suffering. [18][19][20][21][22][23][24][25][26][27][28] To our knowledge, it has not been used before in this clinical context. We chose PRISM since it has several advantages, both practical and conceptual.…”

Section: Discussionmentioning

confidence: 99%

“…15 PRISM has proved to be valid and reliable in various conditions such as chronic illness, pain and advanced cancer. [18][19][20][21][22][23][24] It has been successfully validated in dermatological diseases too. [25][26][27][28] The main purpose of this study was to quantify the burden of suffering in patients with vulvar chronic inflammatory diseases using PRISM.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pictorial Representation of Illness and Self‐Measure to assess the perceived burden in patients with chronic inflammatory vulvar diseases: an observational study

Corazza

Virgili

Toni

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background Chronic inflammatory vulvar diseases can have a huge detrimental impact on patient welfare. A few studies have addressed this issue so far, mainly measuring patients' quality of life or sexual dysfunction. Objective To assess the burden of suffering in patients with chronic inflammatory vulvar diseases using the Pictorial Representation of Illness and Self-Measure (PRISM), a visual, non-verbal instrument. We also assessed (i) the concordance between PRISM and the Dermatology Life Quality Index (DLQI), (ii) whether some variables, both patient-related and disease-related, affect the patient's suffering and quality-of-life impairment. Methods We evaluated for inclusion in this cross-sectional study all patients who attended our Vulva Unit over a 9month period with histologically proven lichen sclerosus (LS), lichen planus (LP), lichen simplex chronicus (LSC), eczema, plasma cell vulvitis and psoriasis (at least five for each disease). Demographics and disease-related subjective and objective scores were recorded. The PRISM and DLQI were administered. Results We included 87 patients affected with LS, 13 with LSC and seven with LP. Median PRISM values (0-273 mm) ranged from 95 to 120 mm, depending on the disease, and median DLQI scores (0-30) were five for all three groups. Neither PRISM nor DLQI scores differed significantly among the three groups. Moderate coherence was found between PRISM and DLQI (q = 0.5455, P < 0.001). Global subjective score was the only variable significantly associated with the degree of suffering and quality-of-life impairment. Conclusions Pictorial Representation of Illness and Self-Measure proved to be a valuable, highly reliable tool for measuring the perceived burden in these patients. In spite of a moderate correlation, PRISM resulted more sensitive in capturing patient distress than DLQI.

show abstract

Assessment of the perceived burden associated with Malignant Melanoma with Pictorial Representation of Illness and Self Measure (PRISM) and Melanoma Concerns Questionnaire (MCQ-28)

Borghi

Flacco

Monti

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

Purpose The impact of malignant melanoma (MM) on patients’ psychophysical well-being has been poorly addressed. We aimed to assess the perceived burden in patients with a diagnosis of MM, using two different tools, one generic and one specific for MM, such as Pictorial Representation of Illness and Self Measure (PRISM) and Melanoma Concerns Questionnaire (MCQ-28), respectively. The correlation between PRISM and MCQ-28 subscales and the relevance of disease and patient-related variables were also investigated. Methods This single-centre, cross-sectional study included all adult consecutive MM patients who attended our Dermatology Unit from December 2020 to June 2021. Demographics and disease-related data were recorded. PRISM and MCQ-28 were administered. Results One hundred and seventy-one patients were included (mean age: 59.5 ±14.9 years.; 48.0% males). Median time from MM diagnosis to inclusion was 36 months. Nearly 80% of the patients had in situ or stage I MM. Overall, 22.2% of the patients reported a PRISM score <100mm and similar percentages provided scores indicating impaired quality of life, as assessed with MCQ-28 subscales. A weak, albeit significant, correlation was found between PRISM scores and ACP, CON and SOC2 subscales. The most relevant association found was that between lower PRISM scores and higher-stage MM. Conclusions In the study population, mostly affected with superficial MM, their perception of the burden associated with MM did not appear either particularly dramatic or disabling. PRISM seems a reliable system for capturing and quantifying the domains correlated with the emotive dimension of MM, especially MM-related concerns and willingness to face life

show abstract

Pictorial Representation of Illness and Self Measure (PRISM): A Novel Visual Instrument to Quantify Suffering in Liver Cirrhosis Patients and Liver Transplant Recipients

Cited by 10 publications

References 28 publications

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Pictorial Representation of Illness and Self‐Measure to assess the perceived burden in patients with chronic inflammatory vulvar diseases: an observational study

Assessment of the perceived burden associated with Malignant Melanoma with Pictorial Representation of Illness and Self Measure (PRISM) and Melanoma Concerns Questionnaire (MCQ-28)

Contact Info

Product

Resources

About